Prostate cancer incidence and mortality in Europe and implications for screening activities: population based study
The epidemiological features of prostate cancer presented here are indicative of overdiagnosis varying over time and across populations. Although the results are ecological in nature and must be interpreted with caution, they do support previous recommendations that any future implementation of prostate cancer screening must be carefully designed with an emphasis on minimising the harms of overdiagnosis.
Authors
- Valentina Lorenzoni (ORCID: https://orcid.org/0000-0002-9948-0301)
- Luigino Dal Maso (ORCID: https://orcid.org/0000-0001-6163-200X)
- Anssi Auvinen (ORCID: https://orcid.org/0000-0003-1125-4818)
- Diego Serraino (ORCID: https://orcid.org/0000-0003-0565-8920)
- Salvatore Vaccarella (ORCID: https://orcid.org/0000-0002-2516-2167)
- Rune Kvåle (ORCID: https://orcid.org/0000-0002-4106-230X)
- Freddie Bray (ORCID: https://orcid.org/0000-0002-3248-7787)
- Mengmeng Li (ORCID: https://orcid.org/0000-0001-6630-7468)
Institutions
- Sun Yat-sen University (CN)
- Scuola Superiore Sant'Anna (IT)
- Tampere University (FI)
- Haukeland University Hospital (NO)
- Tampere University Hospital (FI)
- Centro di Riferimento Oncologico (IT)
- Cancer Registry of Norway (NO)
- Tampere University (FI)
- Sun Yat-sen University Cancer Center (CN)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Centre international de recherche sur le cancer (FR)
Publication Details
- Journal
- BMJ
- Published
- 2024-09-04
- DOI
- https://doi.org/10.1136/bmj-2023-077738
- Citations
- 52
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 21.78
Funders
- World Health Organization